Lynx Dx
Teresa Papadelis is a seasoned professional with extensive experience in sales and account management within the healthcare sector. Currently serving as the Director of Key Accounts at LynxDx since September 2021, Teresa has previously held key positions such as Clinical Sales Representative at Mayo Clinic Laboratories, Cardiovascular Sales Specialist at PULS: GD Bioscience, and Area Sales Manager at Boston Heart Diagnostics. Teresa's career is marked by a progression through various roles in sales management, specializing in areas including aesthetics, diagnostics, and genomic sales across multiple organizations. Educationally, Teresa holds a Bachelor of Applied Science in Biological Psychology from the University of Michigan and has furthered studies in Spanish Language and Cultural Studies at Universidad de Salamanca.
This person is not in any teams
Lynx Dx
MyProstateScore 2.0 is a personalized, comprehensive, data-driven prostate cancer screening solution designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7). The algorithm is specifically optimized for unrivaled accuracy for both previously negative biopsy and biopsy naïve patients.